95656-88-5

基本信息
1-CBZ-3-羟基吡咯烷
N-CBZ-3-羟基吡咯烷
N-CBZ-3-羟基吡咯啉
N-苄氧羰基-3-羟基吡咯烷
N-CBZ-3-羟基吡咯烷产品
N-CBZ-3-羟基吡咯烷,N-苄氧羰基-3-羟基吡咯烷
3-HYDROXY-1-N-CBZ-PY
N-Cbz-3-pyrrolidinol
1-Cbz-3-hydroxypyrrolidine
N-CBZ-3-HYDROXYPYRROLIDINE
3-HYDROXY-1-N-CBZ-PYRROLIDINE
BENZYL 3-HYDROXYPYRROLIDINE-1-CARBOXYLATE
3-HYDROXY-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER
1-Pyrrolidinecarboxylic acid, 3-hydroxy-, phenylMethyl ester
物理化学性质
制备方法

40499-83-0

501-53-1

95656-88-5
向吡咯烷-3-醇(10.45 g,120.1 mmol)的二氯甲烷(300 mL)溶液中依次加入氯甲酸苄酯(24.6 g,144 mmol)和三乙胺(24.3 g,240.2 mmol)。将反应混合物在室温下搅拌12小时。反应完成后,减压浓缩除去溶剂。将残余物溶于乙酸乙酯(100 mL)中,并用去离子水(60 mL)萃取。分离有机层后,依次用去离子水(60 mL)和饱和氯化钠水溶液(60 mL)洗涤。有机层经无水硫酸钠干燥后,减压浓缩。残余物通过硅胶柱色谱法(洗脱剂:石油醚/乙酸乙酯,2:1,v/v)纯化,得到N-CBZ-3-羟基吡咯烷(15.2 g,收率57%)为无色胶状物。LC-MS (ESI): m/z = 222.1 [M + H]+。
参考文献:
[1] Chemical Communications, 2007, # 21, p. 2136 - 2138
[2] Patent: WO2017/216726, 2017, A1. Location in patent: Page/Page column 581
[3] Patent: WO2007/60526, 2007, A1. Location in patent: Page/Page column 44; 71
[4] Journal of Medicinal Chemistry, 2007, vol. 50, # 12, p. 2818 - 2841
[5] Bulletin of the Chemical Society of Japan, 1996, vol. 69, # 1, p. 207 - 215